Positron emission tomography imaging for lymphoma

作者
Guy Jérusalem,Roland Hustinx,Yves P. Beguin,Georges Fillet
出处
期刊:Current Opinion in Oncology [Lippincott Williams & Wilkins]
卷期号:17 (5): 441-445 被引量:25
标识
DOI:10.1097/01.cco.0000174041.29557.5c
摘要

PURPOSE OF REVIEW: To review the current role and the limitations of F-fluorodeoxygenase positron emission tomography in the management of lymphoma, with a particular focus on studies published since January 2004. RECENT FINDINGS: F-fluorodeoxygenase positron emission tomography should be routinely performed at the initial diagnosis of patients with suffering from Hodgkin's disease because it adds useful informations to conventional staging techniques. Residual F-fluorodeoxygenase uptake is an important prognostic factor after one or a few cycles of chemotherapy, but it is clearly too early to change patient treatment on the basis of F-fluorodeoxygenase positron emission tomography results. F-fluorodeoxygenase positron emission tomography is the best noninvasive imaging technique after treatment; however, it is always indicated to correlate positron emission tomography findings with clinical data, other imaging modalities, a biopsy, or all three to reduce the risk of false positive results. There are some concerns about the positive predictive value of positron emission tomography after treatment, especially in childhood lymphoma. Clinicians should be aware of positron emission tomography findings in specific clinical conditions in this patient population. F-fluorodeoxygenase positron emission tomography combined with computed tomography offers advantages over the two used separately and read side by side. It may be particularly useful for the planning of radiation therapy or for the planning of a surgical biopsy. Several studies have shown that F-fluorodeoxygenase positron emission tomography is definitively superior to Ga scintigraphy. New radiotracers such as F-fluorothymidine may be useful for the noninvasive assessment of proliferation in vivo. SUMMARY: F-fluorodeoxygenase positron emission tomography has become the most important nuclear medicine imaging modality in the field of lymphoma. It should be routinely used in the treatment of lymphoma patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研小白发布了新的文献求助10
刚刚
刚刚
yian007发布了新的文献求助10
刚刚
dhy完成签到,获得积分10
1秒前
lulu完成签到,获得积分10
1秒前
Akim的应助被THREE采纳,获得10
2秒前
852的应助被何靖采纳,获得10
2秒前
Lucas的应助被GAATTC采纳,获得10
3秒前
小牧鱼完成签到,获得积分10
3秒前
3秒前
4秒前
幽森之魅完成签到,获得积分10
4秒前
123131发布了新的文献求助10
4秒前
vnewgnl的应助被羽生采纳,获得10
4秒前
欢呼的醉蓝完成签到,获得积分10
4秒前
情怀的应助被Vickyyy采纳,获得10
4秒前
黑米粥发布了新的文献求助200
5秒前
klee完成签到,获得积分10
6秒前
漂亮的烙完成签到,获得积分10
6秒前
ZYC发布了新的文献求助10
6秒前
呆萌绿海发布了新的文献求助10
6秒前
小凡凡关注了科研通微信公众号
6秒前
优美世倌发布了新的文献求助10
6秒前
7秒前
爱学习的白树完成签到 ,获得积分10
7秒前
传奇3的应助被安详的梦秋采纳,获得10
7秒前
7秒前
桥南完成签到,获得积分10
7秒前
Clarissa发布了新的文献求助10
7秒前
mm完成签到,获得积分10
7秒前
我是秦始皇给我转200完成签到,获得积分10
7秒前
fairytaler的应助被xuehufdgierviehc采纳,获得10
8秒前
孙某人完成签到 ,获得积分10
8秒前
lulu发布了新的文献求助10
8秒前
666666完成签到,获得积分10
8秒前
NiuNiu4完成签到,获得积分10
8秒前
顺心觅风发布了新的文献求助10
8秒前
9秒前
Yeezh发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178375
求助须知:如何正确求助?哪些是违规求助? 9569182
关于积分的说明 21802781
捐赠科研通 7773247
什么是DOI,文献DOI怎么找? 3432799
关于科研通互助平台的介绍 2556793
邀请新用户注册赠送积分活动 2478346